Does Rallies show 13F holders for ILMN?

Yes. Rallies tracks hedge fund and 13F ownership data for ILMN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ILMN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ILMN. It does not provide personalized investment advice.

ILMN (Illumina) Stock Analysis - Hedge Fund Holdings

Illumina (ILMN) is a publicly traded Healthcare sector company. As of May 20, 2026, ILMN trades at $141.00 with a market cap of $21.41B and a P/E ratio of 25.43. ILMN moved +0.09% today. Year to date, ILMN is +5.46%; over the trailing twelve months it is +70.80%. Its 52-week range spans $68.70 to $156.66. Analyst consensus is neutral with an average price target of $141.42. Rallies surfaces ILMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ILMN stock?

Hedge funds tracked by Rallies that own ILMN include Corvex Management, Panagora Asset, Duquesne Family, Valueact Holdings, and Icahn Carl. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Illumina.

ILMN Key Metrics

Key financial metrics for ILMN
Metric	Value
Price	$141.00
Market Cap	$21.41B
P/E Ratio	25.43
EPS	$5.52
Dividend Yield	0.00%
52-Week High	$156.66
52-Week Low	$68.70
Volume	1.24M
Avg Volume	0
Revenue (TTM)	$4.39B
Net Income	$853.00M
Gross Margin	66.20%

Top Hedge Funds Holding ILMN

Corvex Management holds 3.83M shares of ILMN, changed +0.00% as of Mar 31, 2026.
Panagora Asset holds 301.81K shares of ILMN, changed +11801.22% as of Mar 31, 2026.
Duquesne Family holds 300.62K shares of ILMN, changed +0.00% as of Jun 30, 2025.
Valueact Holdings holds 243.78K shares of ILMN, changed +0.00% as of Mar 31, 2024.
Icahn Carl holds 220.00K shares of ILMN, changed +450.00% as of Mar 31, 2025.

Latest ILMN News

Illumina Cuts Packaging 87%, Hits 10 Genomes Per Minute Sequencing Pace — May 19, 2026
Illumina jumps as Q1 beat drives higher 2026 outlook and $1.5B buyback — May 4, 2026
Illumina jumps as Q1 results beat and 2026 outlook rises on NovaSeq X momentum — May 1, 2026
Illumina Q1 Revenue Climbs 4.8% to $1.09B; Authorizes $1.5B Buyback — Apr 30, 2026
Illumina jumps as traders position into Q1 2026 earnings due after close — Apr 30, 2026

Recent ILMN Insider Trades

Meister Keith A. sold 12.31K (~$1.77M) on May 14, 2026.
Meister Keith A. sold 52.78K (~$7.64M) on May 14, 2026.
Meister Keith A. sold 25.35K (~$3.71M) on May 14, 2026.

ILMN Analyst Consensus

12 analysts cover ILMN: 0 strong buy, 6 buy, 3 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $141.42.

Common questions about ILMN

Who owns ILMN stock?: Hedge funds tracked by Rallies that own ILMN include Corvex Management, Panagora Asset, Duquesne Family, Valueact Holdings, and Icahn Carl. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Illumina.
Does Rallies show 13F holders for ILMN?: Yes. Rallies tracks hedge fund and 13F ownership data for ILMN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ILMN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ILMN. It does not provide personalized investment advice.